Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Kazia Therapeutics Ltd (KZIA US)
Watchlist
11
Analysis
Health Care
•
Australia
Kazia Therapeutics Limited operates as an biotechnology company. The Company develops anti-cancer drugs, as well as provides pharmaceutical research and development technology solutions. Kazia Therapeutics serves customers globally.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Kazia Therapeutics Ltd
•
06 Sep 2022 14:01
•
Issuer-paid
Kazia Therapeutics - Doubling down on clinical development
Kazia Therapeutics’ FY22 results recapped a busy year focused on strengthening its oncology-focused pipeline. While the year was marked by...
Edison Investment Research
Follow
653 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
08 Aug 2022 16:38
•
Issuer-paid
Kazia Therapeutics - Ambiguity in GBM but pipeline still busy
Kazia Therapeutics has reported that the company’s lead asset paxalisib (PI3K/mTOR inhibitor) has not graduated to Stage 2 of the Phase III GBM...
Edison Investment Research
Follow
654 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
07 Jul 2022 16:04
•
Issuer-paid
Kazia Therapeutics - Paxalisib awarded RPDD in AT/RT
Kazia Therapeutics has announced that the company’s brain-penetrant kinase inhibitor, paxalisib, has been granted Rare Pediatric Disease...
Edison Investment Research
Follow
657 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
21 Jun 2022 19:56
•
Issuer-paid
Kazia Therapeutics - Paxalisib receives ODD for AT/RT
In an encouraging development for Kazia Therapeutics’ efforts towards combating pediatric brain cancers, its lead drug paxalisib has received...
Edison Investment Research
Follow
656 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
24 May 2022 15:58
•
Issuer-paid
Kazia Therapeutics - Deep dive into childhood brain cancer
In light of the positive newsflow from Kazia’s efforts in addressing adult brain cancer, management is leveraging its niche expertise and...
Edison Investment Research
Follow
661 Views
Share
Previous
1
2
3
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.1
x